Close
American Drug Delivery & Formulation Summit
Xylem

Amedra re-launches Adrenaclick to treat anaphylaxis

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

In Vivo CAR-T Engineering Sets a New Oncology Standard

The emergence of chimeric antigen receptor T cell therapy...

Radioligand Therapy Advances in Precision Oncology

The oncology sector is witnessing a fundamental change in...

Proximity Therapeutics Unlock New Druggable Frontiers

The pharmaceutical industry has historically focused on a narrow...
- Advertisement -

Amedra Pharmaceuticals has re-launched a single-dose epinephrine auto-injector Adrenaclick for people with increased risk of anaphylaxis in both 0.15mg and 0.30mg strengths.

Potentially life-threatening allergic reaction, Anaphylaxis onsets rapidly and may cause severe swelling, breathing problems, loss of blood pressure, and death.

Indicated for the treatment of allergic reactions, Adrenaclick will be made available in 0.15mg and 0.30mg doses as two-pack carton.

The emergency injection (shot) of epinephrine is used for allergic reactions caused due to stinging and biting insects (bugs), allergy injections, food, medicines, exercise, or unknown causes.

ย 

World Pharma Today brings together the global pharmaceutical industry โ€” from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives โ€” through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

In Vivo CAR-T Engineering Sets a New Oncology Standard

The emergence of chimeric antigen receptor T cell therapy...

Radioligand Therapy Advances in Precision Oncology

The oncology sector is witnessing a fundamental change in...

Proximity Therapeutics Unlock New Druggable Frontiers

The pharmaceutical industry has historically focused on a narrow...

AI Automation Is Accelerating Drug Discovery at Scale

The traditional pharmaceutical research and development model has long...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป